vimarsana.com
Home
Live Updates
Destiny Crc01 - Breaking News
Pages:
Latest Breaking News On - Destiny crc01 - Page 1 : vimarsana.com
DESTINY-CRC02: Trastuzumab Deruxtecan in HER2+ Metastatic Colorectal Cancer
An overview of the DESTINY-CRC02 study, which looked at trastuzumab deruxtecan in patients with HER2+ metastatic colorectal cancer.
Tanioss-bekaii-saab
Colorectal-cancer
Metastatic-colorectal-cancer
Btrastuzumab
Destiny-crc01
Destiny-crc02
Trastuzumab-deruxtecan
Ild
Kras-mutations
HER2+ Metastatic Colorectal Cancer: Clinical Trial Data With T-DXd
Focused discussion on clinical trial data with trastuzumab deruxtecan in the setting of HER2+ metastatic colorectal cancer.
Evolving-testing
Treatment-strategies
Metastatic-colorectal-cancer
Clinical-trial-data-with
Colorectal-cancer
Crc
Dmcrc
Her2-positive
Ther2
Her2-crc
Her2-antibodies
HER2-Amplified Colorectal Cancer: Clinical Trial Data
A focused discussion on HER2-amplified colorectal cancer and respective clinical trials that inform use of targeted agents in this setting.
Positive-colorectal-cancer
Novel-approaches
Amplified-colorectal-cancer
Clinical-trial-data
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Ther2
Her2-positive
Tucatinib
vimarsana © 2020. All Rights Reserved.